NCT05693701Recruiting
Multicomponent Intervention Study- Blood Donors With High Cholesterol
Implementing a Multicomponent Intervention to Treat Blood Donors With Familial Hypercholesterolemia
Source: ClinicalTrials.gov · Last updated 17 Mar 2026
Brief summary (registry, in English)
The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 11 Jan 2023
- Start date
- 27 Feb 2023
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- University of Texas Southwestern Medical Center
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT05693701
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 27 Feb 2023 to the primary completion date, 30 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently taking medication to lower cholesterol
- Taking any medication that can interact with statins
Other illness
- Chronic liver disease or significantly elevated liver function tests (\> 3 times upper limit)
Other
- Pregnancy
- Identified secondary cause of elevated lipids
Who the study is looking for
- Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria
- Age 18 to 75 years
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UT Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.